Seroatlas · Human Serome Atlas

GRK3

G protein-coupled receptor kinase 3

Also known as: ADRBK2, ARBK2_HUMAN, BARK2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P35626
Gene
GRK3
Ensembl
ENSG00000100077
Chromosome
22
Canonical length
688 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Plasma membrane

OverviewNCBI Gene

The beta-adrenergic receptor kinase specifically phosphorylates the agonist-occupied form of the beta-adrenergic and related G protein-coupled receptors. Overall, the beta adrenergic receptor kinase 2 has 85% amino acid similarity with beta adrenergic receptor kinase 1, with the protein kinase catalytic domain having 95% similarity. These data suggest the existence of a family of receptor kinases which may serve broadly to regulate receptor function. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

688 residues, UniProt reviewed canonical sequence.

>P35626|GRK3
     1  MADLEAVLAD VSYLMAMEKS KATPAARASK RIVLPEPSIR SVMQKYLAER NEITFDKIFN
    61  QKIGFLLFKD FCLNEINEAV PQVKFYEEIK EYEKLDNEED RLCRSRQIYD AYIMKELLSC
   121  SHPFSKQAVE HVQSHLSKKQ VTSTLFQPYI EEICESLRGD IFQKFMESDK FTRFCQWKNV
   181  ELNIHLTMNE FSVHRIIGRG GFGEVYGCRK ADTGKMYAMK CLDKKRIKMK QGETLALNER
   241  IMLSLVSTGD CPFIVCMTYA FHTPDKLCFI LDLMNGGDLH YHLSQHGVFS EKEMRFYATE
   301  IILGLEHMHN RFVVYRDLKP ANILLDEHGH ARISDLGLAC DFSKKKPHAS VGTHGYMAPE
   361  VLQKGTAYDS SADWFSLGCM LFKLLRGHSP FRQHKTKDKH EIDRMTLTVN VELPDTFSPE
   421  LKSLLEGLLQ RDVSKRLGCH GGGSQEVKEH SFFKGVDWQH VYLQKYPPPL IPPRGEVNAA
   481  DAFDIGSFDE EDTKGIKLLD CDQELYKNFP LVISERWQQE VTETVYEAVN ADTDKIEARK
   541  RAKNKQLGHE EDYALGKDCI MHGYMLKLGN PFLTQWQRRY FYLFPNRLEW RGEGESRQNL
   601  LTMEQILSVE ETQIKDKKCI LFRIKGGKQF VLQCESDPEF VQWKKELNET FKEAQRLLRR
   661  APKFLNKPRS GTVELPKPSL CHRNSNGL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GRK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
20 nTPM

Expression across tissuesHPA

Tissue

  • adipose tissue: 20 nTPM
  • spleen: 14 nTPM
  • cerebral cortex: 11 nTPM
  • lymph node: 10 nTPM
  • tonsil: 9.7 nTPM
  • hippocampal formation: 8.5 nTPM

Single-cell type

  • adipocytes: 987 nCPM
  • cdc: 376 nCPM
  • monocytes: 338 nCPM
  • microglia: 316 nCPM
  • macrophages: 316 nCPM
  • b-cells: 312 nCPM

Immune cell

  • non-classical monocyte: 4.3 nTPM
  • intermediate monocyte: 3.8 nTPM
  • naive B-cell: 2.8 nTPM
  • eosinophil: 2.4 nTPM
  • memory B-cell: 2.4 nTPM
  • classical monocyte: 2.3 nTPM

Brain region

  • hippocampal formation: 48 nTPM
  • cerebral cortex: 40 nTPM
  • basal ganglia: 32 nTPM
  • thalamus: 28 nTPM
  • midbrain: 28 nTPM
  • white matter: 26 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GRK3.

Disease | ImmuneIEDB

Conditions an epitope on GRK3 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.36
gnomAD pLI
0.71
DepMap mean gene effect
0
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GRK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GRK3 as an antibody target. Whether an autoantibody or antibody against GRK3 could matter depends on whether native GRK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GRK3 is annotated at the cell surface, where native GRK3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label GRK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GRK3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...